elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q48274676-4B2F0FEF-A3AF-46AF-8221-953615E3E0D5
Q48274676-4B2F0FEF-A3AF-46AF-8221-953615E3E0D5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48274676-4B2F0FEF-A3AF-46AF-8221-953615E3E0D5
Safety and efficacy of semaglutide once weekly vs sitagliptin once daily, both as monotherapy in Japanese people with type 2 diabetes.
P2860
Q48274676-4B2F0FEF-A3AF-46AF-8221-953615E3E0D5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48274676-4B2F0FEF-A3AF-46AF-8221-953615E3E0D5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bc590fc2fdbb61ce6f022fd3566d4c8d8d5869fb
P2860
Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel.